IRVINE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through
Motion and Low Perfusion pulse oximetry, today announced that its management
is scheduled to present at the Lazard Capital Markets 5th Annual Healthcare
Conference at The St. Regis New York in New York, NY on Wednesday, November
19, 2008, at 9:30 a.m. ET. A live audiocast of the presentation will be
available on the Masimo website at http://www.masimo.com. A replay of the
audiocast will be available following the live presentation.
About Masimo
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care -- helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through Motion and Low Perfusion pulse
oximetry, known as Masimo SET, which virtually eliminated false alarms and
increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most reliable SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral perfusion. In
2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough
noninvasive blood constituent monitoring platform that can measure many blood
constituents that previously required invasive procedures. Rainbow SET
continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen
content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and
(PVI(TM)), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion
index (PI), allowing early detection and treatment of potentially
life-threatening conditions. Founded in 1989, Masimo has the mission of
"Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications." Additional information about Masimo
and its products may be found at http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpHb, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse
CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.
Masimo Corporation
Investor Contact:
Mark P. de Raad
Executive Vice President and Chief Financial Officer
Masimo Corporation
(949) 297-7080
mderaad@masimo.com
Media Contact:
Dana Banks
Manager, Public Relations
Masimo Corporation
(949) 297-7348
dbanks@masimo.com
SOURCE Masimo Corporation
Web site: http://www.masimo.com